Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)

China flag China · Delayed Price · Currency is CNY
87.36
+1.37 (1.59%)
At close: Jun 24, 2026
Market Cap12.03B -17.5%
Revenue (ttm)663.57M +26.2%
Net Income202.44M +18.7%
EPS1.47 +17.0%
Shares Out 137.75M
PE Ratio59.51
Forward PEn/a
Dividend0.80 (0.93%)
Ex-Dividend DateMay 26, 2026
Volume886,693
Open85.99
Previous Close85.99
Day's Range85.26 - 89.88
52-Week Range77.53 - 132.94
Beta0.09
Analystsn/a
Price Targetn/a
Earnings DateAug 21, 2026

About SHA:688198

Beijing Balance Medical Technology Co.,Ltd. engages in the research and development, production, sale, and service of animal-derived implantable medical devices in China. The company offers artificial biological heart valves, bovine pericardial and porcine aortic valves; pulmonary valved conduit; tissue antigen removal processor, annuloplasty and valvuloplasty rings, and surgical biological patches; bovine pericardial valves, as well as pulmonary artery valved pipeline, outflow tract single flap patches, etc. Its products are used in heart valv... [Read more]

Sector Healthcare
Founded 2005
Employees 746
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688198
Full Company Profile

Financial Performance

In 2025, SHA:688198's revenue was 620.15 million, an increase of 23.57% compared to the previous year's 501.88 million. Earnings were 193.57 million, an increase of 32.28%.

Financial Statements